CAS: 1423-60-5; 3-Butyn-2-One

该化合物是有机化合物,分类为氯酮.它具有四碳链中第二和第三碳原子的三重结合,有助于其不饱和和和反应.3-丁-2-1的分子式为C4H6O,表明存在4个碳原子,6个氢原子和1个氧原子.这种复合物一般是一种无色液体,有独特的气味,而且已知其挥发性.3-Butyn-2-1,在有机溶剂中可溶解,但由于水中的溶解性有限,它可以参与各种化学反应,包括核循环添加和聚合,使其在有机合成中有用.此外,它可能被用作制药和农用化学生产中的中间体.但是,与许多不饱和化合物一样,如果吸入或吸入有机溶剂,它可能构成健康风险,但需要处理过程中采取适当的安全措施.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

2-methoxy-but-1-en-3-yne but-3-yn-2-ol meso/d,l-3,4-dimethyl-1,5-hexadiyne-3,4-diol 4-trimethylsilyl-3-butyn-2-one 3-piperidino-but-2-enal hepta-2,5-diene2-acetylbicyclo2.2.1hepta-2,5-diene 1-acetyl-1,4-cyclohexadiene 1-(6-methyl-cyclohexa-1,4-dienyl)-ethanone

合成工艺路线路线简述

  • 合成目标产物 3-Butyn-2-One 主要起始原料 3-Butyn-2-Ol
  • (文献来源)合成步骤主要原料 3-Butyn-2-Ol
3-丁炔-2-醇置于chromium(Vi) Oxide,硫酸体系中,用 水 用作溶剂,化学反应 4.5H,反应生成3-丁炔-2-酮
参考文献:1-(2-恶唑烷酮-3-基)-3-甲硅烷氧基-1,3-丁二烯的外消旋和不对称diels-Alder反应.
标题:1-(2-恶唑烷酮-3-基)-3-甲硅烷氧基-1,3-丁二烯的外消旋和不对称diels-Alder反应.
摘要:从容易获得的起始原料制备非手性和手性的1-(2-恶唑烷酮-3-基)-3-甲硅烷氧基-1,3-丁二烯.虽然比母体1-氨基-3-甲硅烷氧基二烯更稳定,但1-(2-恶唑烷酮-3-基)-3-甲硅烷氧基-1,3-丁二烯在狄尔斯-阿尔德反应中仍然具有很高的反应性,比1,3-二烷氧基-1,3-丁二烯(例如,Danishefsky的二烯).检查了具有几种不同的双亲性的非手性和手性二烯的环加成.反应以高产率进行,具有中等至高的内选择性.手性二烯在与α-取代的丙烯醛,马来酸酐和n-苯基马来酰亚胺的环加成中表现出优异的面部选择性.在环加合物还原和水解后,获得的ee范围为22%至> 98%的取代的环己酮.
Doi:10.1021/jo005619Y

海关参考信息

专利信息


专利号:US-3793148-A
优先权日:1972-07-24
标题:Microbiological reduction of 1,3,-dioxo-2-alkylcycloalkanes
发明人:LANZILOTTA R
权利人:SYNTEX CORP
摘要:An improved method of microbiologically reducing a 1,3-dioxo-2alkylcycloalkane using members of a group of compounds which increase the production of the 1 Beta -hydroxy-2 Beta -alkyl-3oxocycloalkane product. The products are useful as intermediates in the total synthesis of useful steroid compounds. Alkyl alcohol and acrylonitrile are illustrated as representative of the useful group of compounds.

专利号:US-4973674-A
优先权日:1987-04-14
标 题:Chiral synthesis of anthracyclines from substituted anthraquinones
发明人:BRASCA MARIA G; PENCO SERGIO
权利人:ERBA CARLO SPA
摘要:Anthracycline glycosides of formula (I): ##STR1## wherein R 1 and R 2 are independently selected from hydrogen, methyl, ethyl or methoxy and pharmaceutically acceptable acid addition salts thereof, which are useful in treatment of human cancer, are prepared by a stereospecific condensation of a derivative of daunosamine of general formula (II): ##STR2## wherein R 3 is an alkyl, perfluoroalkyl or aryl group and R 4 , R 5 , R 6 and R 7 are independently selected from alkyl, aryl or aralkyl having up to ten carbon atoms, with a quinone quinizarine epoxide of general formula (III) ##STR3## and conversion of the product obtained to the anthracycline glycoside of formula (I) or salt thereof.

专利号:US-3578724-A
优先权日:1968-03-04
标 题:Migration and isomerization of acetylenes
发明人:HUBERT ANDRE JULES
权利人:UNION CARBIDE CORP
摘要:PROCESS FOR THE MIGRATION OF ACETYLENIC BONDS AND A PROCESS FOR THE ISOMERIZATION OF HYDROCARBONS CONTAINING ACETYLENIC BONDS TO HYDROCARBONS CONTAINING CONJUGATED UNSATURATION, BY CONTACTING A COMPOUND CONTAINING ONE OR TWO ACETYLENIC BONDS WITH POTASSIUM AMIDE ON ALUMINA. THE UNSATURATED COMPOUNDS PRODUCED BY THE PROCESS OF THE INVENTION ARE USEFUL AS ULTRAVIOLET LIGHT ABSORBERS, AS CROSS-LINKING AGENTS FOR POLYOLEFINIC ELASTOMERS, AND AS INTERMEDIATES IN THE SYNTHESIS OF NEW COMPOUNDS.

专利号:US-4623737-A
优先权日:1984-12-07
标 题:Synthesis of precursors of anti-atherosclerotic furochromones
发明人:YAMASHITA AYAKO
权利人:UPJOHN CO
摘要:The present invention provides novel compositions of matter and processes for their preparation. More particularly, the present invention consists of novel chemical intermediates and associated processes for the preparation of khellin and analogues thereof, which have demonstrated antiatherosclerotic activity.

专利号:US-2011166152-A1
优先权日:2008-10-02
标题 :Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
发明人:LECLERC JEAN-PHILIPPE; LI CHUN SING; RAMTOHUL YEEMAN K
权利人:LECLERC JEAN-PHILIPPE; LI CHUN SING; RAMTOHUL YEEMAN K
摘要:Heteroaromatic compounds of structural formula (I) are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; Type 2 diabetes; insulin resistance; hyperglycemia; Metabolic Syndrome; neurological disease; cancer; and liver steatosis.

专利号:US-4471139-A
优先权日:1982-05-24
标题 :Processes for making 3-methylthiophene-2-carboxaldehyde and intermediates therefor
发明人:ANDREWS GLENN C
权利人:PFIZER
摘要:Processes for preparing isomerically pure 3-methylthiophene-2-carboxaldehyde, an intermediate for synthesis of anthelmintic agents, by reaction of mercaptoacetaldehyde or the dimer, or a polymer thereof, or a dialkylacetal thereof in the presence of a base with (1) methyl vinyl ketone or an alpha- or beta-oxidized derivative of methyl vinyl ketone to form a 3-oxobutylmercaptoacetaldehyde or dialkyl acetal thereof, or an alpha- or beta-substituted derivative thereof which is then converted to 3-methylthiophene-2-carboxaldehyde via appropriate steps including, if necessary, treatment with acid, followed, if necessary, by enamine catalyzed cyclization and, in the case of using methyl vinyl ketone as reactant, a dehydrogenation step; or (2) 3-butyn-2-one to produce a mixture of isomeric 3-oxobut-1-enylmercaptoacetaldehyde or dialkyl acetals thereof which is cyclized to 3-methylthiophene-2-carboxaldehyde. n A further aspect of this invention is an improved process for making dialkyl acetals of 2-mercaptoacetaldehyde which comprises reacting an alkyl vinyl ether with sulfur chloride to produce a bis(2-chloro-2-alkoxy ethyl)disulfide which is then treated with an alcohol to afford a bis(2,2-dialkoxyethyl)disulfide which is reduced under alkaline conditions to 2-mercaptoethyl acetaldehyde alkali metal salt which can be alkylated to a thioether, a valuable intermediate.
安徽济达化工科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jidapharm.com
电话: 0556-5881618 18956990316👤
📞安徽济达化工科技有限公司 ⚠️参考联系方式

销售电话:0556-5881618 18956990316
邮箱:sales@jidapharm.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

安徽省六安经济开发区纬一路中科智能创业园2号楼2层西侧
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

参考标题:Copper Catalyzed Five-Component Domino Strategy For The Synthesis Of Nicotinimidamides
作者:Yu Zhao,Li Li,Zitong Zhou,Man Chen,Weiguang Yang,Hui Luo
摘要:Synthesized By A Copper-Catalyzed Multicomponent Domino Reaction Of Oxime Esters, Terminal Ynones, Sulfonyl Azides, Aryl Aldehydes And Acetic Ammonium. Its Synthetic Pathway Involves The Formation Of A Highly Reactive N-Sulfonyl Acetylketenimine, Characterized By High Selectivity, Combinations Of Potential Nucleophiles And Electrophiles, Mild Reaction Conditions And A Wide Substrate Scope, And Is A Rare

合成参考文献


摘要:Burmester, C.; Haß, O.; Faust, R., Science of Synthesis, (2008) 43, 268.
摘要:Li, W.; Liu, X. H.; Feng, X. M., Science of Synthesis Knowledge Updates, (2021) 1, 11.
摘要:Wu, X.-F., Science of Synthesis Knowledge Updates, (2014) 1, 255.
摘要:Qian, D.; Zhang, J., Science of Synthesis Knowledge Updates, (2017) 1, 2.
摘要:Shimizu, M., Science of Synthesis Knowledge Updates, (2010) 3, 26.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知